Outpatient management of stable acute pulmonary embolism: Proposed accelerated pathway for risk stratification

被引:11
作者
AlMahameed, Amjad
Carman, Teresa L.
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02114 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Sect Vasc Med, Cleveland, OH 44106 USA
关键词
anticoagulation; pharmacotherapy; pulmonary embolism; risk stratification; treatment; venous thromboembolism;
D O I
10.1016/j.amjmed.2007.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary embolism ( PE) is a major health problem and a cause of worldwide morbidity and mortality. The current standard therapy for acute PE encourages admitting patients to the hospital for administration of parenteral anticoagulation therapy as a bridge to oral vitamin K antagonists. Prognostic models that identify patients with stable ( nonmassive) acute PE ( SPE) who are at low risk for adverse outcome have recently been reported. Based on these risk stratification models, hospital- based therapy is warranted for patients with PE who meet the criteria associated with a high risk for adverse outcome. However, a growing body of evidence suggests the feasibility of partial outpatient management and accelerated hospital discharge ( AHD) in a subset of patients with SPE. Prospective validation of these risk stratification models for predicting patient suitability for AHD is needed. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:S18 / S25
页数:8
相关论文
共 62 条
[1]   Clinical and economic aspects of managing venous thromboembolism in the outpatient setting [J].
Agnelli, G ;
Becattini, C .
SEMINARS IN HEMATOLOGY, 2001, 38 (02) :58-66
[2]  
[Anonymous], MED SCI MONIT
[3]  
ARKENTIN TE, 2007, NEW ENGL J MED, V356, P2653
[4]   Derivation and validation of a prognostic model for pulmonary embolism [J].
Aujesky, D ;
Obrosky, DS ;
Stone, RA ;
Auble, TE ;
Perrier, A ;
Cornuz, J ;
Roy, PM ;
Fine, MJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) :1041-1046
[5]   Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism [J].
Aujesky, D ;
Smith, KJ ;
Cornuz, J ;
Roberts, MS .
CHEST, 2005, 128 (03) :1601-1610
[6]   Treatment of deep-vein thrombosis [J].
Bates, SM ;
Ginsberg, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) :268-277
[7]   Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients [J].
Beer, JH ;
Burger, M ;
Gretener, S ;
Bernard-Bagattini, S ;
Bounameaux, H .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (01) :186-187
[8]   Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels [J].
Berkowitz, DE ;
White, R ;
Li, DC ;
Minhas, KM ;
Cernetich, A ;
Kim, S ;
Burke, S ;
Shoukas, AA ;
Nyhan, D ;
Champion, HC ;
Hare, JM .
CIRCULATION, 2003, 108 (16) :2000-2006
[9]   N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism [J].
Binder, L ;
Pieske, B ;
Olschewski, M ;
Geibel, A ;
Klostermann, B ;
Reiner, C ;
Konstantinides, S .
CIRCULATION, 2005, 112 (11) :1573-1579
[10]  
BULLER H, 2005, ANN M INT SOC THROMB